Advertisement

Topics

BioSyn Incorporated Company Profile

14:37 EST 21st November 2017 | BioPortfolio

Biosyn is a specialty pharmaceutical company developing novel, topical-delivery drugs for the treatment and prevention of infectious disease in areas of critical medical need. The Company has built a robust pipeline based upon four technology platforms addressing major anti-infective markets where the use of topical delivery offers significant advantages over systemic therapy.

In the area of HIV and STD prevention, Biosyn has become a leader in the development of microbicides, intra-vaginal gels to prevent or reduce transmission of sexually transmitted diseases (STDs). The Company’s lead compound, Savvy®, has recently completed Phase I/II safety and efficacy studies successfully and is positioned to enter Phase II/III clinical trials for the prevention of chlamydia, herpes simplex virus (HSV), HIV and other sexually transmitted diseases (STDs). A second microbicide candidate, UC781, is in late preclinical development and a third microbicide candidate is in early preclinical development. In addition to its microbicide portfolio, the Company has product development ongoing in several areas including oral complications of immuno-suppression, skin and soft tissue infections, and ophthalmic infections.

Location

1800 Byberry Road, Building 13
Huntingdon Valley
PA
19006
United States of America

Contact

Phone: 215.914.0900
Fax: 215.914.0914
Email: khl@biosyn-inc.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

Gujarat Themis Biosyn Ltd 506879 Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryGujarat Themis Biosyn Ltd GTBL is a medicinal products company that develops, manufactures, and supplies antituberculosis drug. The company offers products such as rifampicin, rifamycins, and l...

Gujarat Themis Biosyn Ltd 506879 Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryGujarat Themis Biosyn Ltd GTBL is a medicinal products company that develops, manufactures, and supplies antituberculosis drug. The company offers products such as rifampicin, rifamycins, and l...

Global Keyhole Limpet Hemocyanin KLH Market Research 2011 2022 [Report Updated: 17042017] Prices from USD $820

SummaryThe Global Keyhole Limpet Hemocyanin KLH market is estimated to reach 8.9 Million USD in 2017. The objective of report is to define, segment, and project the market on the basis of grade, appli...

Global Keyhole Limpet Hemocyanin KLH Market Data Survey Report 2025 [Report Updated: 07102017] Prices from USD $1500

SummaryKLH, which can be used as an active pharmaceutical ingredient API, is a very large, high molecular weight, oxygencarrying glycoprotein made of millions of atoms. There are two KLH subunit forms...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [39 Associated Companies listed on BioPortfolio]

Biosyn Corporation

biosyn markets a variety of novel hemocyanin and immunocyanin products. Currently biosyn manufactures hemocyanin and immunocyanin products from:Giant keyhole limpet (Megathra crenulata). The company i...

BioSyn Incorporated

Biosyn is a specialty pharmaceutical company developing novel, topical-delivery drugs for the treatment and prevention of infectious disease in areas of critical medical need. The Company has built a...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

More Information about "BioSyn Incorporated" on BioPortfolio

We have published hundreds of BioSyn Incorporated news stories on BioPortfolio along with dozens of BioSyn Incorporated Clinical Trials and PubMed Articles about BioSyn Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioSyn Incorporated Companies in our database. You can also find out about relevant BioSyn Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...


Corporate Database Quicklinks



Searches Linking to this Company Record